As biotechnology and pharmaceutical research organizations, we seek to cure diseases, improve health, and secure a better future for everyone in society. Our ability to carry out this important work depends on diversity and internationalism. We stand no chance of succeeding unless we work together and embrace diversity.
Tag Press Release
The symposium on the regional innovative Wachstumskern Praemed.Bio will take place on-line and in English on 29.10.2020.
A famous malaria treatment has been debated as a medical option in preventive measures against COVID-19. Prominent figures continued to market the malaria medicine as a quick breakthrough to combat the pandemic. However, the debate was fierce from the beginning.
Just in time of Christmas, scientists from the German Institute for Human Nutrition (DIfE) and Lipotype GmbH have published their results of their research on the influence of fatty breakfasts and dinners on lipid metabolism. Their newly discovered “biological lipid metabolism clock” fills a gap in nutritional medicine to activate nutrition for prevention and intervention, and to research how specific foods at specific times of the day can contribute to our health or disease.
Obesity is a prime threat to human health. In daily healthcare practice, the go-to indicator of overweight and obesity is the body mass index (BMI). Now, an international team of scientists led by Lipotype introduces a revolutionary A.I. BMI approach towards personalized and precision medicine.
The laureate of the world’s first Lipidomics Excellence Award, Prof. Dr. Anne-Claude Gavin from the University of Geneva , uses the analysis technology of Dresden based Lipotype GmbH for the next breakthrough in her lipid transfer research. The biochemist draws the world’s first molecular “map of lipid highways”, she is tracing the ways of lipid transfer between the membranes of body cells.
Understanding the genetics of lipid species offers information beyond that provided by routine lipid screening, and can help improve risk prediction and treatment. In the first large-scale study, novel lipid-associated genetic variants were identified, some of which were linked with risk for cardiovascular disease, such as heart attacks and strokes. Lipotype provided the technology to measure these lipids – Lipotype Shotgun Lipidomics.
LEA, the Lipidomics Excellence Award, was founded to strengthen life sciences through lipidomics. Over the course of April, the LEA jury deliberated on the submitted projects to announce the three LEA awardees.
Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical products. Lipotype is the worldwide first and only officially GMP certified shotgun lipidomics service provider for pharmaceutical applications.
The Paul Langerhans Institute Dresden, a partner of the DZD, and the University Hospital Carl Gustav Carus joined their forces with Lipotype GmbH and developed a new shotgun lipidomics method for the molecular profiling of brown and white adipose tissue. The results of this collaborative work have now been published in the journal ́Molecular Metabolism ́.